Jake Bauer is an accomplished executive with extensive experience in the biopharmaceutical industry. Currently serving as Chairman of the Board at Simcha Therapeutics since January 2022, Jake also holds board positions at Attralus and Enliven Therapeutics. Previous board roles include a tenure at ARYA Sciences Acquisition Corp V and Phoenix Tissue Repair, Inc. Jake's past experience includes significant roles at Bristol Myers Squibb as a Consultant & Integration Lead, and as Chief Business Officer at MyoKardia. In earlier positions, Jake served as VP of Business Operations at Ablexis, and as Principal at Third Rock Ventures. Jake holds an MBA from Harvard Business School (2005-2007) and a degree from Duke University (1997-2001).
This person is not in the org chart
This person is not in any teams
This person is not in any offices